Author:
Krushkal Julia,Zhao Yingdong,Hose Curtis,Monks Anne,Doroshow James H.,Simon Richard
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Developmental Biology,Genetics,Molecular Biology
Reference131 articles.
1. Pleyer L, Greil R. Digging deep into “dirty” drugs—modulation of the methylation machinery. Drug Metab Rev. 2015;47:252–79.
2. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005;2 Suppl 1:S4–11.
3. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995;55:4525–30.
4. Das PM, Singal R. DNA methylation and cancer. J Clin Oncol. 2004;22:4632–42.
5. Plass C, Pfister SM, Lindroth AM, Bogatyrova O, Claus R, Lichter P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev Genet. 2013;14:765–80.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献